Ausgabe 1/2002
Inhalt (8 Artikel)
A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma
Shin-ichi Takemura, Toshio Kudo, Ryutaro Asano, Masanori Suzuki, Kouhei Tsumoto, Naoki Sakurai, Yu Katayose, Hideaki Kodama, Hiroshi Yoshida, Shinji Ebara, Hisaaki Saeki, Kohzoh Imai, Seiki Matsuno, Izumi Kumagai
Killing activity of human umbilical cord blood-derived TCRValpha24+ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells
Masao Hagihara, Balgansuren Gansuvd, Yoko Ueda, Takahide Tsuchiya, Aya Masui, Kei Tazume, Hiroyasu Inoue, Shunichi Kato, Tomomitsu Hotta
Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines
Pina M. Cardarelli, Maire Quinn, Dana Buckman, Yu Fang, David Colcher, David J. King, Christopher Bebbington, Geoffrey Yarranton
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells
Michele Maio, Ester Fonsatti, Elda Lamaj, Maresa Altomonte, Ilaria Cattarossi, Cristina Santantonio, Cecilia Melani, Filiberto Belli, Flavio Arienti, Mario P. Colombo, Giorgio Parmiani
The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation
Andy Huang, Helen Quinn, Clare Glover, Don C. Henderson, Timothy G. Allen-Mersh
Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells
Angela Märten, Tim Greten, Carsten Ziske, Sabine Renoth, Björn Schöttker, Peter Buttgereit, Frank Schakowski, Alexander von Rücker, Tilman Sauerbruch, Ingo G. Schmidt-Wolf
Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK
Robert C. Rees, Graham Pawelec, Ludmila Müller, Adrian Robins
Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
Juan Hernando, Tjoung-Won Park, Kirsten Kübler, Ruth Offergeld, Harald Schlebusch, Thomas Bauknecht